Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

First and only Estrophasic oral contraceptive approved

Oct. 18, 1996

Menorest approved in Belgium

Oct. 18, 1996

Serono's recombinant human growth hormone approved

Oct. 18, 1996

JT and Tularik to develop new antidiabetic agents

Oct. 18, 1996

Novo Nordisk enters collaboration on PTPase inhibitors

Oct. 18, 1996

U.S. patent covers Celtrix's SomatoKine

Oct. 18, 1996

New NPY antagonists from Warner-Lambert

Oct. 18, 1996

Warner-Lambert describes NK2 antagonists for obesity

Oct. 18, 1996

Antiobesity proteins described by Lilly

Oct. 18, 1996

Anorexigenic dihydropyridine compounds from Bristol-Myers Squibb

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.